Skip to main content
Biophysical Journal logoLink to Biophysical Journal
editorial
. 2016 Jan 5;110(1):278–280. doi: 10.1016/j.bpj.2015.06.070

Rigorous Phenotyping of Cardiac iPSC Preparations Requires Knowledge of Their Resting Potential(s)

Wayne R Giles 1,, Denis Noble 2
PMCID: PMC4805859  PMID: 26745430

Main Text

In a recent “Biophysical Letter” (1), voltage-sensitive dye methods were used to record action potentials from populations of human-induced pluripotent stem-cell-derived cardiac myocytes (iPSC-CMs) that had been maintained in defined cell culture conditions. The main goal of this study was to determine whether chamber-specific (i.e., atrial versus ventricular) action potential waveforms (2) could be identified consistently from these cardiocytes. The data shows that the action potential waveforms depend strongly on cell culture density. In fact, this experimental parameter apparently dominates (and may obscure) detection of the well-known atrial or ventricular action potential waveforms, as well as altering intrinsic pacemaker activity. Accordingly, the main conclusions drawn by these authors are that:

  • 1)

    The cell culture seeding density significantly affects the observed action potential morphology of these iPSC-CM preparations;

  • 2)

    Within an iPSC-CM preparation studied at a predetermined seeding density, the action potentials exhibit a normal distribution of morphologies as opposed to any consistent chamber-specific waveforms; and

  • 3)

    Alteration in the intercellular resistances of these iPSC preparations does not provide an explanation for there being no detectable chamber-specific action potential waveforms.

These interesting findings are potentially very significant. iPSC-CM methodology is importantly involved in essential aspects of both personalized regenerative medicine and safety pharmacology screening for a wide spectrum of either new or repurposed cardiovascular drugs. In these settings (3, 4), and also in fundamental studies of human cardiovascular disease mechanisms, the signature provided by the action potential waveform, and the presence/absence of related pacemaker activity, are the main phenotyping criteria that provide a sign and a measure of progress toward identification of much-needed novel therapeutic agents. However, in our view, additional information is needed before the conclusions from this study (1) can be fully assessed, or accepted without significant reservations.

It is well known that the waveform and baseline stability of the mammalian cardiac action potential depends strongly on the value of the resting membrane potential (5, 6) In part, this is because the resting potential regulates the excitability of both myocytes and Purkinje fiber cells. However, the same K+ channels (IK1) that regulate the resting potential in atria and ventricles also produce the outward current that is responsible for the final phase of repolarization of the action potential (7). Unfortunately, voltage-sensitive dye recordings of action potential waveforms (as used in this study) cannot yield any direct information concerning the resting potential, or IK1 (1). Detailed recordings of the resting potential, and voltage-clamp measurements of the highly nonlinear underlying background K+ current IK1 or Kir2.1, are needed as part of the investigation of action potential morphology.

In fact, the importance of appropriate expression levels of IK1 for valid phenotyping of human pluripotent stem cell-derived cardiomyocytes has been clearly established by articles from the laboratories of Bett et al. (8), and Lieu et al. (9) (see Fig. S2D). Here, IK1 is described as an environmental cue. This is perhaps apt, because it is very important to draw attention to the very strong (but also nonlinear) dependence on the size of IK1 as a function of plasma K+ levels (7).

A very recent article on electrophysiological properties of human induced-pluripotent stem-cell-derived cardiomyocytes used the dynamic voltage-clamp technique to inject predetermined IK1 current waveforms into these targeted myocytes (10). The expected pattern of results was obtained (see their Fig. 3), and from the data in this article, it is clear that it is the outward limb of the IK1 current-voltage relationship that is of critical importance (8).

An additional reason for needing to have detailed knowledge of the resting potential and underlying K+ current(s) when carrying out studies such as the one reported by Du et al. (1) is that the intrinsic biophysical properties of IK1 can also alter intercellular coupling and thus can change/modulate electrotonic cell-cell interactions (11). Variations in IK1, and in particular changes in the negative slope region of its ion transfer or current-voltage relationship, can effectively homogenize the resulting action potential waveforms in a fashion that depends strongly on a number of cell culture conditions. This includes (but is not limited to) cell density. For example, it is well known that IK1 current density decreases as a function of the time during which mammalian myocytes are held in conventional two-dimensional culture conditions (12), including methods similar to those used by Du et al. (1).

Patch-on-a-chip methods, including semiautomated planar patch-clamp platforms have been advanced for the study of these hiPSc cardiocytes (13). Ideally, these experiments should include detailed assessment of the resting potential and recordings of action potentials in each targeted cell studied at physiological temperatures (13). To accomplish this, protocols must involve repeated assessments of the patch seal resistance and the input resistance of the myocyte (14). In fact, it would seem to be prudent to combine these essential measurements with a determination of the complete I-V curve for IK1, and an assessment of the impedance profile of action potential during its plateau (15).

In summary, the “Biophysical Letter” by Du et al. (1) contains important new information regarding novel phenotyping procedures. Their results characterize iPSC cardiomyocytes under conventional cell culture conditions. However, the unqualified conclusion that chamber-specific action potential waveforms cannot be identified from these preparations needs to be reevaluated. To be certain of this, accurate measurements of the resting potential and the underlying background inwardly rectifying K+ current (IK1) density are both needed. As mentioned (8, 9), this requirement has already been recognized for electrophysiology studies of cardiac stem cells. Thus, Bett et al. (8) have reported that adding an IK1 current in their action potential clamp studies of stem cells stabilizes the resting potential and action potential waveform. This result was anticipated based on a number of previous reports that, in two-dimensional cell culture conditions, IK1 progressively and quite quickly runs down (12). This progressive decrease in IK1 in ventricular myocytes can be linked to the concomitant changes in the density of the transverse tubule system (12) and the recognition that IK1 is strongly expressed in the T-tubule membrane (16). iPSC cardiomyocytes have only a minimal T-tubule system. The immature microanatomical phenotype of these iPSC cardiomyocytes may contribute to their propensity to show spontaneous pacemaker activity that appears to be modulated by electrogenic current flow due to Na+/Ca2+ exchange activity (17). If this is the case, the value of the maximum diastolic potential or resting potential is again of critical importance due to the intrinsic biophysical properties of the Na+/Ca2+ ion transfer or I-V relationship (18).

It is also known that soon after mammalian cardiac cells grow to confluence in cell culture, the density of a number of ionic currents can change significantly, and connexin expression is also augmented (19). The advantages of using patient-specific iPS cells for disease modeling and regenerative medicine are considerable (9, 10, 17, 20). However, detailed understanding of the electrophysiological principles that regulate the resting potential, action potential waveforms, cell-cell interactions, and/or pacemaker activity and [Ca2+]i homeostasis (21) is required for these applications and for safety pharmacology (22).

Acknowledgments

Operating grants (Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada), and salary support (Alberta Innovates Health Solutions) to W.R.G., are gratefully acknowledged.

Editor: Randall Rasmusson.

References

  • 1.Du D.T., Hellen N., Terracciano C.M.N. Action potential morphology of human induced pluripotent stem cell-derived cardiomyocytes does not predict cardiac chamber specificity and is dependent on cell density. Biophys. J. 2015;108:1–4. doi: 10.1016/j.bpj.2014.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ma J., Guo L., January C.T. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am. J. Physiol. Heart Circ. Physiol. 2011;301:H2006–H2017. doi: 10.1152/ajpheart.00694.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Navarrete E.G., Liang P., Wu J.C. Screening drug-induced arrhythmia using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation. 2013;128(Suppl 1):S3–S13. doi: 10.1161/CIRCULATIONAHA.112.000570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Moretti A., Bellin M., Laugwitz K.L. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 2010;363:1397–1409. doi: 10.1056/NEJMoa0908679. [DOI] [PubMed] [Google Scholar]
  • 5.Bouchard R., Clark R.B., Giles W.R. Changes in extracellular K+ concentration modulate contractility of rat and rabbit cardiac myocytes via the inward rectifier K+ current IK1. J. Physiol. 2004;556:773–790. doi: 10.1113/jphysiol.2003.058248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Moore L.E., Clark R.B., Giles W.R. Comparison of steady-state electrophysiological properties of isolated cells from bullfrog atrium and sinus venosus. J. Membr. Biol. 1986;89:131–138. doi: 10.1007/BF01869709. [DOI] [PubMed] [Google Scholar]
  • 7.Shimoni Y., Clark R.B., Giles W.R. Role of an inwardly rectifying potassium current in rabbit ventricular action potential. J. Physiol. 1992;448:709–727. doi: 10.1113/jphysiol.1992.sp019066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bett G.C., Kaplan A.D., Rasmusson R.L. Electronic “expression” of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells. Heart Rhythm. 2013;10:1903–1910. doi: 10.1016/j.hrthm.2013.09.061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lieu D.K., Fu J.D., Li R.A. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Arrhythm. Electrophysiol. 2013;6:191–201. doi: 10.1161/CIRCEP.111.973420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Meijer van Putten R., Mengarelli I., Wilders R. Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1. Front. Physiol. 2015;6:7. doi: 10.3389/fphys.2015.00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Joyner R.W., Kumar R., van Ginneken A.C. Electrical interactions between a rabbit atrial cell and a nodal cell model. Am. J. Physiol. 1998;274:H2152–H2162. doi: 10.1152/ajpheart.1998.274.6.H2152. [DOI] [PubMed] [Google Scholar]
  • 12.Mitcheson J.S., Hancox J.C., Levi A.J. Action potentials, ion channel currents and transverse tubule density in adult rabbit ventricular myocytes maintained for 6 days in cell culture. Pflugers Arch. 1996;431:814–827. doi: 10.1007/s004240050073. [DOI] [PubMed] [Google Scholar]
  • 13.Scheel O., Frech S., Knott T. Action potential characterization of human induced pluripotent stem cell-derived cardiomyocytes using automated patch-clamp technology. Assay Drug Dev. Technol. 2014;12:457–469. doi: 10.1089/adt.2014.601. [DOI] [PubMed] [Google Scholar]
  • 14.Wilson J.R., Clark R.B., Giles W.R. Measurement of the membrane potential in small cells using patch clamp methods. Channels (Austin) 2011;5:530–537. doi: 10.4161/chan.5.6.17484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kaur J., Nygren A., Vigmond E.J. Fitting membrane resistance along with action potential shape in cardiac myocytes improves convergence: application of a multi-objective parallel genetic algorithm. PLoS One. 2014;9:e107984. doi: 10.1371/journal.pone.0107984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Clark R.B., Tremblay A., Fiset C. T-tubule localization of the inward-rectifier K+ channel in mouse ventricular myocytes: a role in K+ accumulation. J. Physiol. 2001;537:979–992. doi: 10.1111/j.1469-7793.2001.00979.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kim J.J., Yang L., Salama G. Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells. J. Mol. Cell. Cardiol. 2015;81:81–93. doi: 10.1016/j.yjmcc.2015.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Baczkó I., Giles W.R., Light P.E. Resting membrane potential regulates Na+-Ca2+ exchange-mediated Ca2+ overload during hypoxia-reoxygenation in rat ventricular myocytes. J. Physiol. 2003;550:889–898. doi: 10.1113/jphysiol.2003.043372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hershman K.M., Levitan E.S. Cell-cell contact between adult rat cardiac myocytes regulates Kv1.5 and Kv4.2 K+ channel mRNA expression. Am. J. Physiol. 1998;275:C1473–C1480. doi: 10.1152/ajpcell.1998.275.6.C1473. [DOI] [PubMed] [Google Scholar]
  • 20.Liang P., Lan F., Wu J.C. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation. 2013;127:1677–1691. doi: 10.1161/CIRCULATIONAHA.113.001883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hwang H.S., Kryshtal D.O., Knollmann B.C. Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories. J. Mol. Cell. Cardiol. 2015;85:79–88. doi: 10.1016/j.yjmcc.2015.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Mirams G.R., Davies M.R., Noble D. Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing. Br. J. Pharmacol. 2012;167:932–945. doi: 10.1111/j.1476-5381.2012.02020.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES